Trademark Overview
On Wednesday, June 5, 2024, a trademark application was filed for SEQUVAX with the United States Patent and Trademark Office. The USPTO has given the SEQUVAX trademark a serial number of 98585952. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, June 5, 2024. This trademark is owned by Seqirus UK Limited. The SEQUVAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Providing medical and scientific research information about the results of clinical trials for coronavirus and COVID-19 vaccines; providing medical and scientific research information in the field of coronavirus and COVID-19 vaccines and coronavirus and COVID-19 vaccine clinical trials.
